Biohaven Pharma (BHVN)
14.75
-0.76 (4.90%)
Upcoming Events
Latest Headlines
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload
July 20, 2026 7:30 AM - PR NewsWire
Form 3 Biohaven Ltd. For: Jul 09 Filed by: Volles Warren Karl
July 17, 2026 6:00 PM - SEC Filing
Form 8-K Biohaven Ltd. For: Jul 09
July 9, 2026 5:11 PM - SEC Filing
Biohaven names new discovery head as CSO shifts to part-time role
July 9, 2026 5:01 PM - StreetInsider
Biohaven Announces Scientific Leadership Transitions
July 9, 2026 5:00 PM - PR NewsWire
Form SCHEDULE 13G/A Biohaven Ltd. Filed by: Janus Henderson Group Ltd.
July 8, 2026 5:44 PM - SEC Filing
Biohaven completes enrollment in focal epilepsy drug trial
June 30, 2026 7:31 AM - StreetInsider
Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator
June 30, 2026 7:30 AM - PR NewsWire
Biohaven Pharma (BHVN) call put ratio 7.5 calls to 1 put as share price down 4.7%
June 29, 2026 3:27 PM - StreetInsider
BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
June 29, 2026 11:51 AM - StreetInsider
Biohaven starts Phase 3 trial of BHV-1300 for Graves' disease
June 29, 2026 7:31 AM - StreetInsider
Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease
June 29, 2026 7:30 AM - PR NewsWire
BofA Securities Downgrades Biohaven Pharma (BHVN) to Underperform
June 29, 2026 6:10 AM - StreetInsider
Biohaven Pharma (BHVN) PT Raised to $20 at Deutsche Bank
June 26, 2026 7:11 AM - StreetInsider
Increasing unusual option volume: BHVN DOMO CLPT OIH CVLT PEGA OTLK VT
June 17, 2026 10:15 AM - StreetInsider
Biohaven begins first human trial of brain-penetrant drug BHV-8100
June 1, 2026 7:31 AM - StreetInsider
Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation
June 1, 2026 7:30 AM - PR NewsWire
Form 8-K Biohaven Ltd. For: May 26
May 27, 2026 5:15 PM - SEC Filing
Raymond James on Biohaven Pharma (BHVN) with shares up 7%: 'Promising Degrader Data Sets Ahead of R&D Day'
May 27, 2026 10:16 AM - StreetInsider
Biohaven reports positive patient data for autoimmune disease drugs
May 27, 2026 7:31 AM - StreetInsider
Biohaven Reports Positive Clinical Biomarker and Patient Data: First MoDE and TRAP Extracellular Protein Degraders Achieve Deep, Rapid, Selective Lowering of Disease-Driving Antibodies in Graves' Dise
May 27, 2026 7:30 AM - PR NewsWire
Biohaven shares clinical data on epilepsy drug opakalim
May 26, 2026 7:31 AM - StreetInsider
Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile
May 26, 2026 7:30 AM - PR NewsWire
Form SCHEDULE 13G/A Biohaven Ltd. Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 12:37 PM - SEC Filing
Biohaven Pharma (BHVN) PT Lowered to $18 at Morgan Stanley
May 13, 2026 8:19 AM - StreetInsider
H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharma (BHVN)
May 12, 2026 6:52 AM - StreetInsider
Form 8-K Biohaven Ltd. For: May 04
May 5, 2026 4:18 PM - SEC Filing
Biohaven Pharma (BHVN) PT Lowered to $22 at RBC Capital
May 5, 2026 6:29 AM - StreetInsider
Biohaven Pharma (BHVN) Misses Q1 EPS by 4c
May 4, 2026 5:11 PM - StreetInsider
Form 424B5 Biohaven Ltd.
May 4, 2026 5:08 PM - SEC Filing
Biohaven Pharma (BHVN) files mixed shelf
May 4, 2026 4:26 PM - StreetInsider
Form S-3ASR Biohaven Ltd.
May 4, 2026 4:24 PM - SEC Filing
Form 10-Q Biohaven Ltd. For: Mar 31
May 4, 2026 4:08 PM - SEC Filing
Form 8-K Biohaven Ltd. For: May 04
May 4, 2026 4:07 PM - SEC Filing
Form 8-K Biohaven Ltd. For: Apr 28
May 4, 2026 4:02 PM - SEC Filing
Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results
May 4, 2026 4:02 PM - PR NewsWire
Form 4 Biohaven Ltd. For: Apr 28 Filed by: Mehta Kishan
April 30, 2026 8:10 PM - SEC Filing
Form 4 Biohaven Ltd. For: Apr 28 Filed by: Bailey Gregory
April 30, 2026 8:09 PM - SEC Filing
Form 4 Biohaven Ltd. For: Apr 28 Filed by: Heffernan Michael Thomas
April 30, 2026 8:09 PM - SEC Filing
Form 4 Biohaven Ltd. For: Apr 28 Filed by: Antonijevic Irina
April 30, 2026 8:08 PM - SEC Filing
Form 4 Biohaven Ltd. For: Apr 28 Filed by: CHILDS JOHN W
April 30, 2026 8:08 PM - SEC Filing
Form 4 Biohaven Ltd. For: Apr 28 Filed by: HUGIN ROBERT J
April 30, 2026 8:08 PM - SEC Filing
Form 4 Biohaven Ltd. For: Apr 28 Filed by: GREGORY JULIA P
April 30, 2026 8:07 PM - SEC Filing
Full Article List
